Nevada Revised Statutes Title 40. Public Health and Safety § 454.690. Availability of investigational drug, biological product or device; prohibition on preventing access to investigational drug, biological product or device; penalty
Current as of January 01, 2021 | Updated by FindLaw Staff
Welcome to FindLaw's Cases & Codes, a free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.
1. The manufacturer of an investigational drug, biological product or device may provide or make available the investigational drug, biological product or device to a patient in this State who has been diagnosed with a terminal condition if a physician has prescribed or recommended the investigational drug, biological product or device to the patient as authorized pursuant to NRS 630.3735 or 633.6945.
2. A manufacturer who provides or makes available an investigational drug, biological product or device to a patient pursuant to subsection 1 may:
(a) Provide the investigational drug, biological product or device to the patient without charge; or
(b) Charge the patient only for the costs associated with the manufacture of the investigational drug, biological product or device.
3. An officer, employee or agent of this State shall not prevent or attempt to prevent a patient from accessing an investigational drug, biological product or device that is authorized to be provided or made available to a patient pursuant to this section.
4. A violation of any provision of this section is a misdemeanor.
5. As used in this section:
(a) “Biological product” has the meaning ascribed to it in 42 U.S.C. § 262.
(b) “Investigational drug, biological product or device” means a drug, biological product or device that:
(1) Has successfully completed Phase 1 of a clinical trial;
(2) Has not been approved by the United States Food and Drug Administration; and
(3) Is currently being tested in a clinical trial that has been approved by the United States Food and Drug Administration.
(c) “Terminal condition” means an incurable and irreversible condition that, without the administration of life-sustaining treatment, will, in the opinion of the attending physician, result in death within 1 year.
Cite this article: FindLaw.com - Nevada Revised Statutes Title 40. Public Health and Safety § 454.690. Availability of investigational drug, biological product or device; prohibition on preventing access to investigational drug, biological product or device; penalty - last updated January 01, 2021 | https://codes.findlaw.com/nv/title-40-public-health-and-safety/nv-rev-st-454-690/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
Was this helpful?